StockData
Harrow, Inc. logo

Harrow, Inc. (HROW) stock

HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$32.16+2.64 (+8.94%)

Close on Nov 18, 2026Market cap $1.21BP/E –Yield –

Harrow operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Harrow's operating income for the twelve months ending Jun 30, 2026 was -$2.75M, down 119.1% year over year. For fiscal 2025 it was $30.52M, up 245.9% from the year before. The highest annual figure on record is $30.52M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$30.52M+245.9%
FY2024Dec 31, 2024$8.82M+1946.9%
FY2023Dec 31, 2023$431.00K-77.5%
FY2022Dec 31, 2022$1.92M+18.9%
FY2021Dec 31, 2021$1.61M+319.2%
FY2020Dec 31, 2020$385.00K–
FY2019Dec 31, 2019-$4.80M–
FY2018Dec 31, 2018-$5.22M–
FY2017Dec 31, 2017-$12.16M–
FY2016Dec 31, 2016-$15.88M–
FY2015Dec 31, 2015-$14.82M–
FY2014Dec 31, 2014-$10.15M–
FY2013Dec 31, 2013-$7.69M–
FY2012Dec 31, 2012-$4.18M–
FY2011Dec 31, 2011-$939.23K–
FY2010Dec 31, 2010-$2.50M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$11.01M-196.5%
Q1 FY2026Mar 31, 2026-$22.08M–
Q4 FY2025Dec 31, 2025$15.59M+20.9%
Q3 FY2025Sep 30, 2025$14.75M+1016.4%
Q2 FY2025Jun 30, 2025$11.41M+645.7%
Q1 FY2025Mar 31, 2025-$11.23M–
Q4 FY2024Dec 31, 2024$12.90M–
Q3 FY2024Sep 30, 2024$1.32M-24.3%
Q2 FY2024Jun 30, 2024$1.53M-34.9%
Q1 FY2024Mar 31, 2024-$6.93M-672.6%
Q4 FY2023Dec 31, 2023-$4.88M–
Q3 FY2023Sep 30, 2023$1.74M–
Q2 FY2023Jun 30, 2023$2.35M+39.2%
Q1 FY2023Mar 31, 2023$1.21M-42.4%
Q4 FY2022Dec 31, 2022-$1.78M–
Q3 FY2022Sep 30, 2022-$94.00K–
Q2 FY2022Jun 30, 2022$1.69M-59.5%
Q1 FY2022Mar 31, 2022$2.10M-28.0%
Q4 FY2021Dec 31, 2021-$1.76M-166.8%
Q3 FY2021Sep 30, 2021-$3.72M-332.7%
Q2 FY2021Jun 30, 2021$4.17M–
Q1 FY2021Mar 31, 2021$2.92M–
Q4 FY2020Dec 31, 2020$2.63M+183.6%
Q3 FY2020Sep 30, 2020$1.60M–
Q2 FY2020Jun 30, 2020-$3.21M–
Q1 FY2020Mar 31, 2020-$628.00K–
Q4 FY2019Dec 31, 2019$926.00K–
Q3 FY2019Sep 30, 2019-$4.40M–
Q2 FY2019Jun 30, 2019-$767.00K–
Q1 FY2019Mar 31, 2019-$556.00K–
Q4 FY2018Dec 31, 2018-$2.16M–
Q3 FY2018Sep 30, 2018-$649.00K–
Q2 FY2018Jun 30, 2018-$624.00K–
Q1 FY2018Mar 31, 2018-$1.78M–
Q4 FY2017Dec 31, 2017-$2.15M–
Q3 FY2017Sep 30, 2017-$2.76M–
Q2 FY2017Jun 30, 2017-$3.02M–
Q1 FY2017Mar 31, 2017-$4.23M–
Q4 FY2016Dec 31, 2016-$3.51M–
Q3 FY2016Sep 30, 2016-$4.61M–

More Harrow figures

See a number that looks wrong?